CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial

Phase: PHASE2 | Sponsor: Section for Affective Disorders; Northern Stockholm Psychiatry | Compound: Psilocybin

Status

recruiting

Institution

Section for Affective Disorders; Northern Stockholm Psychiatry

Start date

2024-04-17

End date

2025-12-01

Registry ID

NCT06319378

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.